{"id":51850,"date":"2022-12-12T14:02:17","date_gmt":"2022-12-12T13:02:17","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/posterity-health-national-male-fertility-company-announces-their-second-regional-expansion-in-2022\/"},"modified":"2022-12-12T14:02:17","modified_gmt":"2022-12-12T13:02:17","slug":"posterity-health-national-male-fertility-company-announces-their-second-regional-expansion-in-2022","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/posterity-health-national-male-fertility-company-announces-their-second-regional-expansion-in-2022\/","title":{"rendered":"Posterity Health, National Male Fertility Company, Announces Their Second Regional Expansion in 2022"},"content":{"rendered":"
\n

INDIANAPOLIS–(BUSINESS WIRE)–Posterity Health<\/a>, the only Virtual Male Fertility Center of Excellence that offers personalized care, educational resources, and effective treatments, continues its rapid expansion into the Great Lakes Region, which includes Illinois, Indiana, Michigan, and Ohio. With this growth, Posterity Health is proud to welcome reproductive urologist, Dr. Jason Kovac to lead the new region. Dr. Kovac is immediately accepting new patients.\n<\/p>\n

<\/a><\/p>\n

\nPosterity Health offers a combination of virtual visits, at-home diagnostics and in-person consults to help assess and improve a male\u2019s fertility status. \u201cDealing with infertility issues are often a painful and isolating process,\u201d said Pam Pure, Chief Executive Officer and Founder of Posterity Health. \u201cRapidly expanding into the Great Lakes Region helps us realize our mission to bring equity to fertility by providing access to inclusive male fertility care to all couples trying to conceive. Our goal is to unite the couple early in their conception journey so everyone can find their best path to pregnancy.\u201d Services in the Great Lakes Region include the Male Fertility Assessment for males who want to assess their fertility status and the Male Fertility Work-up, which is designed for males with an abnormal semen analysis and includes a personalized treatment plan. Posterity Health also provides a portfolio of Men\u2019s Health solutions including vasectomies, vasectomy reversals, varicocele repairs, testosterone therapy, as well as treatment for erectile dysfunction and scrotal pain.\n<\/p>\n

\nDr. Jason Kovac<\/a> is a highly regarded Male Fertility and Men\u2019s Health expert. He is a fellowship-trained reproductive urologist and is dual board-certified in both the United States and Canada. Dr. Kovac obtained his MD and Ph.D. from the University of Western Ontario and completed his urology residency at McMaster University in Hamilton, Ontario. Dr. Kovac has extensive male fertility research experience and has trained with leading Urologists at the Baylor College of Medicine. \u201cI am pleased to join Posterity Health, the only Center of Excellence for Male Fertility Care,\u201d said Dr. Kovac. \u201cI will bring a focused awareness of the male\u2019s contribution to a couple’s fertility journey in order to optimize success. Through an individualized, patient-centered approach using an integration of medicine and surgery, I will improve access to care through technology while maximizing what patients can expect from their physician.\u201d\n<\/p>\n

\nPosterity Health has a technology driven patient experience. The company offers their male patients and their partners access to its Digital Heath Platform, which is designed to support and improve male factor infertility. It is customized to connect and communicate with males to answer their questions, provide education on the role they play in the conception process, and define the most common male fertility diagnoses and treatments. Dr. Barrett Cowan, Founder and Chief Medical Officer, explains that \u201cMale factor infertility impacts over 50% of couples who are having trouble conceiving. It\u2019s more common than people think and it\u2019s often treatable once identified. The addition of Dr. Kovac allows us to help more couples and reinforces our commitment to provide the expertise required to help each couple determine their best path to pregnancy.”\n<\/p>\n

\nMore about Posterity Health<\/b>\n<\/p>\n

\nPosterity Health\u2019s protocols are developed in conjunction with its Medical Advisory Board, which consists of the most renowned fertility leaders in the country, including Dr. Peter Schlegel, James J Colt Professor of Urology at Weill Cornell Medicine, Dr. James Smith, the Director of the Male Reproductive Health Center at UCSF, and Dr. Stan Honig, the Director of Men\u2019s Health at Yale University.\n<\/p>\n

\nTo learn more about Posterity Health, visit posterityhealthin.com<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nFor media inquiries please contact Pam@posterityhealth.com<\/a>.\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

INDIANAPOLIS–(BUSINESS WIRE)–Posterity Health, the only Virtual Male Fertility Center of Excellence that offers personalized care, educational resources, and effective treatments, continues its rapid expansion into the Great Lakes Region, which includes Illinois, Indiana, Michigan, and Ohio. With this growth, Posterity Health is proud to welcome reproductive urologist, Dr. Jason Kovac to lead the new region. … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-51850","6":"format-standard","7":"category-industry"},"yoast_head":"\nPosterity Health, National Male Fertility Company, Announces Their Second Regional Expansion in 2022 - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/posterity-health-national-male-fertility-company-announces-their-second-regional-expansion-in-2022\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Posterity Health, National Male Fertility Company, Announces Their Second Regional Expansion in 2022 - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"INDIANAPOLIS–(BUSINESS WIRE)–Posterity Health, the only Virtual Male Fertility Center of Excellence that offers personalized care, educational resources, and effective treatments, continues its rapid expansion into the Great Lakes Region, which includes Illinois, Indiana, Michigan, and Ohio. With this growth, Posterity Health is proud to welcome reproductive urologist, Dr. Jason Kovac to lead the new region. ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/posterity-health-national-male-fertility-company-announces-their-second-regional-expansion-in-2022\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-12-12T13:02:17+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20221212005030\/en\/1660340\/21\/POS-SecondaryLogo-CMYK.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/posterity-health-national-male-fertility-company-announces-their-second-regional-expansion-in-2022\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/posterity-health-national-male-fertility-company-announces-their-second-regional-expansion-in-2022\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Posterity Health, National Male Fertility Company, Announces Their Second Regional Expansion in 2022\",\"datePublished\":\"2022-12-12T13:02:17+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/posterity-health-national-male-fertility-company-announces-their-second-regional-expansion-in-2022\\\/\"},\"wordCount\":608,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/posterity-health-national-male-fertility-company-announces-their-second-regional-expansion-in-2022\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221212005030\\\/en\\\/1660340\\\/21\\\/POS-SecondaryLogo-CMYK.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/posterity-health-national-male-fertility-company-announces-their-second-regional-expansion-in-2022\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/posterity-health-national-male-fertility-company-announces-their-second-regional-expansion-in-2022\\\/\",\"name\":\"Posterity Health, National Male Fertility Company, Announces Their Second Regional Expansion in 2022 - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/posterity-health-national-male-fertility-company-announces-their-second-regional-expansion-in-2022\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/posterity-health-national-male-fertility-company-announces-their-second-regional-expansion-in-2022\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221212005030\\\/en\\\/1660340\\\/21\\\/POS-SecondaryLogo-CMYK.jpg\",\"datePublished\":\"2022-12-12T13:02:17+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/posterity-health-national-male-fertility-company-announces-their-second-regional-expansion-in-2022\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/posterity-health-national-male-fertility-company-announces-their-second-regional-expansion-in-2022\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/posterity-health-national-male-fertility-company-announces-their-second-regional-expansion-in-2022\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221212005030\\\/en\\\/1660340\\\/21\\\/POS-SecondaryLogo-CMYK.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221212005030\\\/en\\\/1660340\\\/21\\\/POS-SecondaryLogo-CMYK.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/posterity-health-national-male-fertility-company-announces-their-second-regional-expansion-in-2022\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Posterity Health, National Male Fertility Company, Announces Their Second Regional Expansion in 2022\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Posterity Health, National Male Fertility Company, Announces Their Second Regional Expansion in 2022 - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/posterity-health-national-male-fertility-company-announces-their-second-regional-expansion-in-2022\/","og_locale":"en_US","og_type":"article","og_title":"Posterity Health, National Male Fertility Company, Announces Their Second Regional Expansion in 2022 - Pharma Trend","og_description":"INDIANAPOLIS–(BUSINESS WIRE)–Posterity Health, the only Virtual Male Fertility Center of Excellence that offers personalized care, educational resources, and effective treatments, continues its rapid expansion into the Great Lakes Region, which includes Illinois, Indiana, Michigan, and Ohio. With this growth, Posterity Health is proud to welcome reproductive urologist, Dr. Jason Kovac to lead the new region. ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/posterity-health-national-male-fertility-company-announces-their-second-regional-expansion-in-2022\/","og_site_name":"Pharma Trend","article_published_time":"2022-12-12T13:02:17+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20221212005030\/en\/1660340\/21\/POS-SecondaryLogo-CMYK.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/posterity-health-national-male-fertility-company-announces-their-second-regional-expansion-in-2022\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/posterity-health-national-male-fertility-company-announces-their-second-regional-expansion-in-2022\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Posterity Health, National Male Fertility Company, Announces Their Second Regional Expansion in 2022","datePublished":"2022-12-12T13:02:17+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/posterity-health-national-male-fertility-company-announces-their-second-regional-expansion-in-2022\/"},"wordCount":608,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/posterity-health-national-male-fertility-company-announces-their-second-regional-expansion-in-2022\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221212005030\/en\/1660340\/21\/POS-SecondaryLogo-CMYK.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/posterity-health-national-male-fertility-company-announces-their-second-regional-expansion-in-2022\/","url":"https:\/\/pharma-trend.com\/en\/posterity-health-national-male-fertility-company-announces-their-second-regional-expansion-in-2022\/","name":"Posterity Health, National Male Fertility Company, Announces Their Second Regional Expansion in 2022 - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/posterity-health-national-male-fertility-company-announces-their-second-regional-expansion-in-2022\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/posterity-health-national-male-fertility-company-announces-their-second-regional-expansion-in-2022\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221212005030\/en\/1660340\/21\/POS-SecondaryLogo-CMYK.jpg","datePublished":"2022-12-12T13:02:17+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/posterity-health-national-male-fertility-company-announces-their-second-regional-expansion-in-2022\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/posterity-health-national-male-fertility-company-announces-their-second-regional-expansion-in-2022\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/posterity-health-national-male-fertility-company-announces-their-second-regional-expansion-in-2022\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20221212005030\/en\/1660340\/21\/POS-SecondaryLogo-CMYK.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20221212005030\/en\/1660340\/21\/POS-SecondaryLogo-CMYK.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/posterity-health-national-male-fertility-company-announces-their-second-regional-expansion-in-2022\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Posterity Health, National Male Fertility Company, Announces Their Second Regional Expansion in 2022"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/51850","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=51850"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/51850\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=51850"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=51850"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=51850"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}